{{Rsnum
|rsid=754524
|Chromosome=2
|position=21088669
|Orientation=minus
|GMAF=0.168
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 54.0 | 40.7 | 5.3
| HCB | 81.8 | 17.5 | 0.7
| JPT | 80.5 | 19.5 | 0.0
| YRI | 99.3 | 0.7 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 81.8 | 17.5 | 0.7
| CHD | 78.5 | 17.8 | 3.7
| GIH | 80.2 | 16.8 | 3.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 60.3 | 34.5 | 5.2
| MKK | 89.7 | 9.6 | 0.6
| TSI | 57.8 | 37.3 | 4.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23262498
|Title=Impact of geneticfactorsondyslipidemia in HIV-infected patients starting antiretroviral therapy
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}